3.16MMarket Cap-3026P/E (TTM)
0.310High0.260Low869.27KVolume0.310Open0.315Pre Close236.91KTurnover10.77%Turnover RatioLossP/E (Static)12.14MShares8.65052wk High-1.19P/B2.10MFloat Cap0.20152wk Low--Dividend TTM8.07MShs Float8.650Historical High--Div YieldTTM15.88%Amplitude0.201Historical Low0.272Avg Price1Lot Size
60 Degrees Pharmaceuticals Stock Forum
NEWS
60 Degrees Pharmaceuticals Funds Babesia spp Testing in Chronic Fatigue Patient Samples in NC State College of Veterinary Medicine Study
$Palantir(PLTR.US)$
$60 Degrees Pharmaceuticals(SXTP.US)$
$Xilio Therapeutics(XLO.US)$
$Snowflake(SNOW.US)$
$VinFast Auto(VFS.US)$
$Scorpius Holdings(SCPX.US)$
NEWS
60 Degrees Pharmaceuticals Receives FDA Comments on Tafenoquine-Babesiosis Clinical Trial Protocol; No Material Changes Required
60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) has received comments from the FDA on the protocol for a clinical trial studying tafenoquine in treating babesiosis, a life-threatening tick-borne disease. The comments do not require material changes to the trial design. The Company is moving forward with trial planning a...
No comment yet